October 2020 - Page 6 of 6 - BioMedWire (BMW)

MondayOct 05, 2020 9:45 am

Some Cerebral Palsy Cases Could Be Due to a Patient’s Genes, Research Finds

In an article that was published in Nature Genetics, scientists have confirmed that almost 14% of all cerebral palsy cases may be connected to an individual’s genes and indicate that those genes control how brain circuits are wired in early development. Cerebral palsy is a brain disorder that affects an individual’s ability to move and maintain posture and balance. It’s a motor disability that is common in childhood. The National Institute of Neurological Disorders was the main funder behind this research. The scientists’ findings were based on the biggest genetic study of cerebral palsy that has ever been conducted. Additionally,…

FridayOct 02, 2020 1:30 pm

New Study Confirms Children Are Significantly Less Likely to Contract Coronavirus

A new study that centered on global coronavirus transmission data discovered that young people and children are about 40% less likely to be infected with COVID-19 as compared to adults when exposed to an individual who has the virus. The study, which was co-led by researchers from University College London and published in JAMA Pediatrics, added more than 13,900 studies to its May pre-print in order to update their meta-analysis and systematic review. The additional studies were used to understand how susceptible children were to the coronavirus and whether they transmitted the infection to others. Professor Russell Viner, who is…

FridayOct 02, 2020 10:42 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) is “One to Watch”

VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders Two of the company’s drug candidates have received an FDA fast track designation, including for the treatment of social anxiety disorder, major depressive disorder and neuropathic pain. The global CNS therapeutics market is estimated to reach $130 billion by 2025 The two most common mental health conditions – anxiety and depression – cost the global economy an estimated $1 trillion each year VistaGen is committed to developing and commercializing multiple new generation medications that go beyond the standard of care…

FridayOct 02, 2020 10:30 am

High Fructose Intake May Worsen Inflammatory Bowel Disease

A new study by the Stony Brook University indicates that fructose consumption may actually aggravate an intestinal inflammation into inflammatory bowel disease. The study, which was led by David Montrose of the Stony Brook University Renaissance School of Medicine, was published in the Cellular and Molecular Gastroenterology and Hepatology online journal. According to the U.S. CDC, roughly three million Americans are diagnosed with Inflammatory Bowel Diseases (“IBD”) each year, which is a one million increase in the number of cases in comparison with cases in the late 90s. The number of IBD cases appears to be increasing globally as well.…

ThursdayOct 01, 2020 3:00 pm

Engineers Link Computers to Brains Using 3D Implants

Up until now, we have only seen scientists linking the brain to a monitor in sci-fi movies where the evil scientist wants to manipulate the subject’s brain or fry it to pudding. This is now a near-reality after a team of neuroscientists and engineers from the St. Petersburg State University in Russia, Technische Universität Dresden in Germany and University of Sheffield in the UK used the power of 3D printing to improve neural implant technology. The study has been published in Nature Biomedical Engineering. The team was led by Professor Pavel Musienko from St. Petersburg and Professor Ivan Minev, from…